Catalyst Pharmaceuticals Inc
NASDAQ: CPRX
$21.12
-$0.03 (-0.1%)
Closing Price on November 21, 2024
CPRX Stock Chart and Intraday Price
CPRX Stock Data
| Asset Type | Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Address | 355 ALHAMBRA CIRCLE, SUITE 1250, CORAL GABLES, FL, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 2,025.30M USD |
| Shares Outstanding | 119,065,000 |
CPRX Articles
Tuesday's top analyst upgrades and downgrades included Applied Materials, Bill, Catalyst Pharmaceutical, CVS Health, Elastic, Hawaiian Electric Industries and Walmart.
Published:
Wednesday's additional top analyst upgrades and downgrades were on Amazon.com, Beyond Meat, Catalyst Pharmaceuticals, Dick’s Sporting Goods, Macy’s, Medtronic, Twitter, XPeng and more.
Published:
The "next" GameStop is certain to be hit fast and hard. Perhaps the WallStreetBets message board on Reddit will target Catalyst Pharmaceuticals or TherapeuticsMD stock.
Published:
Some small-cap companies will screen as having deep value, but many value stocks are deemed to be "cheap" because they lack any new catalysts and opportunities.
Published:
Robinhood has become the dominant discount brokerage platform over the last year. It had 4.3 million average revenue trades in June, which is a critical metric in the industry. This is higher than...
Published:
Some companies Robinhood traders find most attractive are very risky bets. A hit to the financials of one of these companies or a piece of bad news could easily trigger an extreme sell-off of the...
Published:
A new SunTrust Robinson Humphrey research report focuses in on biotech companies that have upcoming clinical data that could prove to be huge.
Published:
Last Updated:
The broad markets are inching forward on Wednesday after hitting new highs in what has been known as the Trump rally. Although the SPDR S&P Biotech ETF (NYSEMKT: XBI) is up about 1% on the day,...
Published:
Last Updated:
The the top analyst upgrades, downgrades and initiations seen on Wednesday morning include Broadcom, Flex, Genworth Financial, Micron Technology, Salesforce.com, UBS and Wal-Mart.
Published:
Last Updated:
Apple, Twitter and other companies punished shareholders last week, and analysts expect more earnings disappointments going forward.
Published:
Last Updated:
Catalyst Pharmaceuticals saw its shares get halved just Tuesday morning alone, following a business update regarding its Lambert-Eaton myasthenic syndrome treatment.
Published:
Last Updated:
Rite Aid has announced that it will acquire EnvisionRx for $2 billion from the private equity firm TPG Capital.
Published:
ThinkstockCatalyst Pharmaceutical Partners Inc. (NASDAQ: CPRX) announced positive topline results from its Phase 3 clinical trial of Firdapse for the symptomatic treatment of Lambert-Eaton Myasthenic...
Published:
August 27, 2013: U.S. markets opened lower Tuesday morning with worries over possible U.S. actions in Syria weighing prices down all day. The S&P Case-Shiller house price index was strong again...
Published:
Last Updated:
thinkstockHere are today’s five biggest gaining stocks at closing: Superconductor Technologies Inc. (NASDAQ: SCON) is up 134.9% at $5.45. MEMSIC Inc. (NASDAQ: MEMS) is up 50.8% at $4.07. Ceasars...
Published:
Last Updated: